中图分类号:
陈芳, 张弛, 崔敏. 利奈唑胺注射液致重度血小板减少1例[J]. 中国药物警戒, 2017, 14(4): 254-254.
| [1] Noskin G A, Siddiqui F, Stosor V, et al. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci[J]. Antimicrob Agents Chemother, 1999, 43(8): 2059-2062. [2] Ozkaya-Parlakay A, Kara A, Celik M, et al. Early lactic acidosis associated with linezolid therapy in paediatric patients[J]. Int J Antimicrob Agents, 2014, 44(4): 334-336. [3] Attassi K, Hershberger E, Alam R, et al. Thrombocytopenia associated with linezolid therapy[J]. Clin Infect Dis, 2002, 34(5): 695-698. [4] Matsumoto K, Takeda Y, Takeshita A, et al. Renal function as a predictor of linezolid-induced thrombocytopenia[J]. Int J Antimicrob Agents. 2009, 33(1): 98-99. [5] Gerson S L, Kaplan S L, Bruss J B, et al. Hematologic effects of linezolid: summary of clinical experience[J]. Antimicrob Agents Chemother, 2002, 46(8): 2723-2726. [6] Antal E J, Hendershot P E, Batts D H, et al. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine[J]. J Clin Pharmacol, 2001, 41(5): 552-562. [7] Lin Y H, Wu V C, Tsai I J, et al. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency[J]. Int J Antimicrob Agents, 2006, 28(4): 345-351. [8] Wu V C, Wang Y T, Wang C Y, et al. High frequency of thrombocytopenia and anemia among patients with end-stage renal disease[J]. Clin Infect Dis, 2006, 42(1):66-72 [9] 董海燕, 邹雅敏, 董亚琳, 等. Logistic模型和ROC曲线对利奈唑胺致血小板减少症的预测分析[J]. 中国医院药学杂志, 2013(22): 1827-1831. [10] Soriano A, Ortega M, Garcia S, et al. Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse eveents induced by linezolid[J]. Antimicrob Afents Chemother, 2007, 51(7):2559-2663. [11] Matsumoto K, Takeshita A, Ikawak, et al. Higer linezolid exposure and higher frequency of thrombocytopeniain patients with renal dysfunction[J]. Int J Antimicrob Agents, 2010, 36(2):179-181. [12] Grau S, Morales-Molina J A, Mateude Antonio J, et al. Linezolid:low pretreatment platelet values could increase the risk of thrombocytopenia[J]. J Antimicro Chemother, 2005 56(2):440-1. [13] Hiraki Y, Tsuji Y, Matsumoto K, et al. Influence of Linezolid Clearance on the Induction of Thromobocytopenia and Reduction of Hemoglobin[J]. Am J Med Sci, 2011, 342(6):456-460. [14] Niwa T, Suzuki A, Sakakibara S, et al. Reftrospective cohort chart review study of fafctorsassociated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy[J]. Cli Ther, 2009, 31(10):2126-2133. [15] Sasaki T, Takane H, Ogawa K, et al. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients[J]. Antimicrob Agents Chemother, 2011,55(5):1867-186173. |
| [1] | 孙绮悦, 赵荣华, 郭姗姗, 包蕾, 耿子涵, 李舒冉, 徐英莉, 张敬升, 崔晓兰, 孙静. 羚羊感冒口服液多重药理作用研究[J]. 中国药物警戒, 2024, 21(2): 127-131. |
| [2] | 赵荣华, 孙静, 包蕾, 耿子涵, 陶夏莉, 张敬升, 庞博, 徐英莉, 曹姗, 李舒冉, 郭姗姗, 王道涵, 崔晓兰. 基于免疫调节探讨葛根汤颗粒治疗小鼠病毒性肺炎的作用机制[J]. 中国药物警戒, 2024, 21(2): 132-136. |
| [3] | 包蕾, 耿子涵, 李舒冉, 冀祖恩, 赵荣华, 孙静, 郭姗姗, 崔晓兰. 瞬时受体电位通道在病毒性肺炎发展过程中的关键作用[J]. 中国药物警戒, 2024, 21(2): 137-140. |
| [4] | 贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166. |
| [5] | 李嘉昕, 刘慧敏, 钱文秀, 马宁, 宋丽丽, 李遇伯. 基于中药系统毒理学数据库的中药致肾毒性及药物规律研究[J]. 中国药物警戒, 2024, 21(2): 173-180. |
| [6] | 范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184. |
| [7] | 张建, 方慧华. 某院活血化瘀类中药注射剂使用评价标准建立的探索[J]. 中国药物警戒, 2024, 21(2): 185-189. |
| [8] | 王珊, 谢波, 刘慧敏, 李志浩. 基于FAERS数据库对塞来昔布不良事件信号的分析[J]. 中国药物警戒, 2024, 21(2): 190-194. |
| [9] | 李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198. |
| [10] | 徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203. |
| [11] | 郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207. |
| [12] | 方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210. |
| [13] | 李娜, 郭军, 郭文佳, 吕茵茵, 李彩宏, 牟向东. 奥马珠单抗注射剂治疗哮喘致迟发型皮肤过敏反应1 例分析[J]. 中国药物警戒, 2024, 21(2): 211-212. |
| [14] | 曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218. |
| [15] | 朱盈, 沈璐, 李岚, 吴建民, 高晓洁. 新法规体系下我国牙膏不良反应监测工作分析与思考[J]. 中国药物警戒, 2024, 21(2): 219-222. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
